| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |